UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

IL-8 as Antibody Therapeutic Target in Inflammatory Diseases: Reduction of Clinical Activity in Palmoplantar Pustulosis

The Journal of immunology (1950), 2008-07, Vol.181 (1), p.669-679

2008

Volltextzugriff (PDF)

Neutralization of IL-8 prevents the induction of dermatologic adverse events associated with the inhibition of epidermal growth factor receptor

PloS one, 2012-06, Vol.7 (6), p.e39706

2012

Volltextzugriff (PDF)

Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model

The Journal of clinical investigation, 2003-11, Vol.112 (10), p.1571-1580

2003

Volltextzugriff (PDF)

Neuroblastoma metastatic to the central nervous system: Survival analyses from the German Childhood Cancer Registry and the literature

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.10555-10555

2017

Volltextzugriff (PDF)

Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma

Blood, 2007-06, Vol.109 (11), p.4655-4662

2007

Volltextzugriff (PDF)

Chemotherapy-Refractory Diffuse Large B-Cell Lymphomas (DLBCL) Are Effectively Killed by Ofatumumab-Induced Complement-Mediated Cytoxicity

Blood, 2007-11, Vol.110 (11), p.2346-2346

2007

Volltextzugriff (PDF)

Long-wave UVA offers partial protection against UVB-induced immune suppression in human skin

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2000-06, Vol.108 (12), p.825-830

2000

Volltextzugriff (PDF)

A human CD4 monoclonal antibody for the treatment of T-cell lymphoma combines inhibition of T-cell signaling by a dual mechanism with potent Fc-dependent effector activity

Cancer research (Chicago, Ill.), 2007-10, Vol.67 (20), p.9945-9953

2007

Volltextzugriff (PDF)

Application of staphylococcal enterotoxin B on normal and atopic skin induces up-regulation of T cells by a superantigen-mediated mechanism

Journal of allergy and clinical immunology, 2000-04, Vol.105 (4), p.820-826

2000

Volltextzugriff (PDF)

Release of nickel ions from stainless steel alloys used in dental braces and their patch test reactivity in nickel-sensitive individuals

Contact dermatitis, 2003-06, Vol.48 (6), p.300-304

2003

Volltextzugriff (PDF)

Psoriatic Epidermal Cells Demonstrate Increased Numbers and Function of Non-Langerhans Antigen-presenting Cells

Journal of investigative dermatology, 1989-02, Vol.92 (2), p.190-195

1989

Volltextzugriff (PDF)

Mechanisms of Cyclosporine A Inhibition of Antigen-Presenting Activity in Uninvolved and Lesional Psoriatic Epidermis

Journal of investigative dermatology, 1990-05, Vol.94 (5), p.649-656

1990

Volltextzugriff (PDF)

In vivo UVB irradiation induces clustering of Fas (CD95) on human epidermal cells

Experimental dermatology, 2003-12, Vol.12 (6), p.791-798

2003

Volltextzugriff (PDF)

Effects of cyclosporine on immunologic mechanisms in psoriasis

Journal of the American Academy of Dermatology, 1990-12, Vol.23 (6), p.1318-1328

1990

Volltextzugriff (PDF)

Zanolimumab (HuMax-CD4™), a Fully Human Monoclonal Antibody: Efficacy and Safety in Patients with Relapsed or Treatment-Refractory Non-Cutaneous CD4+ T-Cell Lymphoma

BLOOD, 2007, Vol.110 (11), p.3409-3409

2007

Volltextzugriff (PDF)

Association of TNFA gene polymorphism at position -308 with susceptibility to irritant contact dermatitis

Immunogenetics (New York), 2000-03, Vol.51 (3), p.201-205

2000

Volltextzugriff (PDF)

Zanolimumab, a Fully Human Monoclonal Antibody: Early Results of an Ongoing Clinical Trial in Patients with CD4+ Mycosis Fungoides (MF) Type CTCL (Stage IB-IVB) Who Are Refractory or Intolerant to Targretin and One Other Standard Therapy

Blood, 2006-11, Vol.108 (11), p.2731-2731

2006

Volltextzugriff (PDF)

Alopecia Areata: An Immunologic Disease?

Journal of investigative dermatology, 1991-05, Vol.96 (5), p.S89-S90

Baadsgaard, Ole

1991

Volltextzugriff (PDF)

S108 Immunological cells in psoriasis pathogenesis

Journal of the European Academy of Dermatology and Venereology, 1997-09, Vol.9, p.S27-S27

Baadsgaard, Ole

1997

Volltextzugriff (PDF)

Zanolimumab, a Fully Human Monoclonal Antibody: Preliminary Results of an Ongoing Clinical Trial in CD4+ Peripheral T-Cell Lymphomas (PTCL)

BLOOD, 2006, Vol.108 (11), p.2723-2723

2006

Volltextzugriff (PDF)

High Dermal Mast Cell Prevalence is a Predisposing Factor for Basal Cell Carcinoma in Humans

Journal of investigative dermatology, 2000-08, Vol.115 (2), p.317-320

2000

Volltextzugriff (PDF)

Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma. Commentary

Blood, 2007, Vol.109 (11)

2007

Volltextzugriff (PDF)

Inhibitors of cysteine cathepsin and calpain do not prevent ultraviolet-B-induced apoptosis in human keratinocytes and HeLa cells

Archives of Dermatological Research, 2004-07, Vol.296 (2), p.67-73

2004

Volltextzugriff (PDF)

Interferon Gamma-Treated Keratinocytes Activate T Cells in the Presence of Superantigens: Involvement of Major Histocompatibility Complex Class II Molecules

Journal of investigative dermatology, 1994-02, Vol.102 (2), p.150-154

1994

Volltextzugriff (PDF)

The potential role of Staphylococcus aureus superantigens in atopic eczema

Journal of the European Academy of Dermatology and Venereology, 1996-07, Vol.7, p.S8-S11

1996

Volltextzugriff (PDF)

1 – 25 von 84

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(72)
Mit Volltextzugriff
(72)

Publikationsform

Sprache

Englisch
(84)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

IL-8 as Antibody Therapeutic Target in Inflammatory Diseases: Reduction of Clinical Activity in Palmoplantar Pustulosis

Neutralization of IL-8 prevents the induction of dermatologic adverse events associated with the inhibition of epidermal growth factor receptor

Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model

Neuroblastoma metastatic to the central nervous system: Survival analyses from the German Childhood Cancer Registry and the literature

Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma

Chemotherapy-Refractory Diffuse Large B-Cell Lymphomas (DLBCL) Are Effectively Killed by Ofatumumab-Induced Complement-Mediated Cytoxicity

Long-wave UVA offers partial protection against UVB-induced immune suppression in human skin

A human CD4 monoclonal antibody for the treatment of T-cell lymphoma combines inhibition of T-cell signaling by a dual mechanism with potent Fc-dependent effector activity

Application of staphylococcal enterotoxin B on normal and atopic skin induces up-regulation of T cells by a superantigen-mediated mechanism

Release of nickel ions from stainless steel alloys used in dental braces and their patch test reactivity in nickel-sensitive individuals

Psoriatic Epidermal Cells Demonstrate Increased Numbers and Function of Non-Langerhans Antigen-presenting Cells

Mechanisms of Cyclosporine A Inhibition of Antigen-Presenting Activity in Uninvolved and Lesional Psoriatic Epidermis

In vivo UVB irradiation induces clustering of Fas (CD95) on human epidermal cells

Effects of cyclosporine on immunologic mechanisms in psoriasis

Zanolimumab (HuMax-CD4™), a Fully Human Monoclonal Antibody: Efficacy and Safety in Patients with Relapsed or Treatment-Refractory Non-Cutaneous CD4+ T-Cell Lymphoma

Association of TNFA gene polymorphism at position -308 with susceptibility to irritant contact dermatitis

Zanolimumab, a Fully Human Monoclonal Antibody: Early Results of an Ongoing Clinical Trial in Patients with CD4+ Mycosis Fungoides (MF) Type CTCL (Stage IB-IVB) Who Are Refractory or Intolerant to Targretin and One Other Standard Therapy

Alopecia Areata: An Immunologic Disease?

S108 Immunological cells in psoriasis pathogenesis

Zanolimumab, a Fully Human Monoclonal Antibody: Preliminary Results of an Ongoing Clinical Trial in CD4+ Peripheral T-Cell Lymphomas (PTCL)

High Dermal Mast Cell Prevalence is a Predisposing Factor for Basal Cell Carcinoma in Humans

Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma. Commentary

Inhibitors of cysteine cathepsin and calpain do not prevent ultraviolet-B-induced apoptosis in human keratinocytes and HeLa cells

Interferon Gamma-Treated Keratinocytes Activate T Cells in the Presence of Superantigens: Involvement of Major Histocompatibility Complex Class II Molecules

The potential role of Staphylococcus aureus superantigens in atopic eczema

Suchergebnisse filtern